BMI1 and metastatic malignant neoplasm in the lymph nodes: Notably, in GC patients, elevated Bmi-1 expression is closely correlated with unfavorable prognostic factors, including large tumor size, differentiation, invasion, lymph node metastasis, and distant metastasis [12,13,14].